Natrox
Cambridge
About Natrox
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound. NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air and directs it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $48.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2024)
- Website: natroxwoundcare.com
- Phone: +44 01223 661830
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/natrox-87423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.